Adial Pharmaceuticals Implements 1-for-25 Reverse Stock Split to Maintain Nasdaq Listing

summarizeSummary

Adial Pharmaceuticals will effect a 1-for-25 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement, with split-adjusted trading commencing February 6, 2026.

check_boxKey Events

• 1-for-25 Reverse Stock Split Finalized

  The company filed an amendment to its Certificate of Incorporation to effect a 1-for-25 reverse stock split, approved by stockholders on August 1, 2025, and the Board on February 4, 2026. The split becomes legally effective at 11:59 p.m. ET on February 5, 2026.

• Trading on Split-Adjusted Basis

  Common Stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market when it opens on February 6, 2026, under the existing ticker symbol 'ADIL'.

• Purpose: Nasdaq Listing Compliance

  The primary goal of the reverse stock split is to increase the per-share trading price to meet Nasdaq's minimum bid price requirement of $1.00, thereby maintaining the company's listing.

• Shares Outstanding Reduced

  The reverse split will reduce the number of outstanding shares from approximately 27.8 million to approximately 1.1 million. Proportional adjustments will be made to outstanding equity awards and warrants.

auto_awesomeAnalysis

Adial Pharmaceuticals has finalized a 1-for-25 reverse stock split, effective February 5, 2026, with split-adjusted trading beginning February 6, 2026. This action is primarily aimed at raising the per-share trading price to meet Nasdaq's minimum bid price requirement of $1.00 and avoid delisting. The company's stock is currently trading near its 52-week low, underscoring the urgency of this measure. While necessary for continued listing, reverse stock splits are generally viewed negatively by the market as they often signal financial distress or a struggle to maintain investor confidence. The reduction in outstanding shares from approximately 27.8 million to 1.1 million will proportionally adjust equity awards and warrants.